Pfizer and BioNTech are seeking FDA authorization on the vaccine for 5 to 11-year-olds, and it could come as flu season is in full swing.
Pfizer and BioNTech are seeking FDA authorization on the vaccine for 5 to 11-year-olds, and it could come as flu season is in full swing.